Oxycodone DETERx, an extended-release, tamper-resistant formulation for management of chronic pain

被引：2
|
作者：
Kopecky, E. [1 ]
Fleming, A. [1 ]
Varanasi, R. [1 ]
Saim, S. [1 ]
Mayock, S. [1 ]
机构：
[1] Coll Pharmaceut Inc, Cumberland, RI USA
来源：
JOURNAL OF PAIN | 2013年 / 14卷 / 04期
关键词：
D O I：
10.1016/j.jpain.2013.01.609
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [1] Oxycodone DETERx, an extended-release, abuse-deterrent formulation for management of patients with chronic pain and chronic pain with dysphagia
    Kopecky, E.
    Fleming, A.
    Findlen, K.
    Mayock, S.
    Varanasi, R.
    Saim, S.
    JOURNAL OF PAIN, 2014, 15 (04): : S90 - S90
  • [2] Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets
    Eisenhauer, Tiffani D.
    Matchett, Mike
    Heasley, Ralph
    Morton, Terri
    Devarakonda, Krishna
    Giuliani, Michael
    Young, Jim L.
    Barrett, Thomas
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (01) : 157 - 165
  • [3] Opioid extended-release tablets with improved tamper-resistant properties
    Bartholomaeus, Johannes H.
    Arkenau-Maric, Elisabeth
    Galia, Eric
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (08) : 879 - 891
  • [4] Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation
    Peacock, Amy
    Degenhardt, Louisa
    Hordern, Antonia
    Larance, Briony
    Cama, Elena
    White, Nancy
    Kihas, Ivana
    Bruno, Raimondo
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (12) : 1265 - 1272
  • [5] Oxycodone DETERx®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain
    Gudin J.
    Pain and Therapy, 2016, 5 (2) : 171 - 186
  • [6] A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone
    Peacock, Amy
    Degenhardt, Louisa
    Larance, Briony
    Cama, Elena
    Lintzeris, Nicholas
    Ali, Robert
    Bruno, Raimondo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (12) : 1321 - 1333
  • [7] Relative bioavailability of a new tamper resistant extended-release oxycodone/naloxone combination product
    Stahlberg, H.
    Brett, M.
    Schwier, S.
    Philipp, A.
    JOURNAL OF PAIN, 2014, 15 (04): : S86 - S86
  • [8] The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone
    Setnik, Beatrice
    Roland, Carl L.
    Cleveland, Jody M.
    Webster, Lynn
    PAIN MEDICINE, 2011, 12 (04) : 618 - 631
  • [9] Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain
    Luo, Zhu
    Miao, Jia
    Shu, Shiqing
    Wang, Ying
    Zhu, Xiaohong
    Hu, Chao
    Shen, Yali
    CLINICAL DRUG INVESTIGATION, 2020, 40 (02) : 139 - 148
  • [10] Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain
    Zhu Luo
    Jia Miao
    Shiqing Shu
    Ying Wang
    Xiaohong Zhu
    Chao Hu
    Yali Shen
    Clinical Drug Investigation, 2020, 40 : 139 - 148
12345